Nicholas Company, Inc. Dexcom Inc Transaction History

Nicholas Company, Inc.

$5.86 Billion
Q3 2024

A detailed history of Nicholas Company, Inc. transactions in Dexcom Inc stock. As of the latest transaction made, Nicholas Company, Inc. holds 965 shares of DXCM stock, worth $77,238. This represents 0.0% of its overall portfolio holdings.

Number of Shares

965

Previous 767,651 99.87%

Holding current value

$77,238

Previous $87 Million 99.93%

% of portfolio

0.0%

Previous 1.48%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$64.0 - $116.06 $49.1 Million - $89 Million	-766,686 Reduced 99.87%	965 $64,000
Q2 2024 Jul 24, 2024	SELL	$110.31 - $140.45 $7,170 - $9,129	-65 Reduced 0.01%	767,651 $87 Million
Q1 2024 May 14, 2024	SELL	$114.22 - $140.1 $8.52 Million - $10.5 Million	-74,595 Reduced 8.86%	767,716 $106 Million
Q4 2023 Feb 13, 2024	BUY	$75.49 - $124.16 $5.11 Million - $8.41 Million	67,751 Added 8.75%	842,311 $105 Million
Q3 2023 Feb 13, 2024	BUY	$86.06 - $137.93 $23.7 Million - $38 Million	275,515 Added 55.21%	774,560 $72.3 Million
Q3 2023 Nov 13, 2023	BUY	$86.06 - $137.93 $23.7 Million - $38 Million	275,515 Added 55.21%	774,560 $72.3 Million
Q4 2022 Feb 13, 2024	SELL	$84.98 - $122.67 $11,472 - $16,560	-135 Reduced 0.03%	499,045 $56.5 Million
Q4 2022 Feb 09, 2023	SELL	$84.98 - $122.67 $11,472 - $16,560	-135 Reduced 0.03%	499,045 $56.5 Million
Q3 2022 Feb 13, 2024	BUY	$76.35 - $94.18 $3.08 Million - $3.79 Million	40,280 Added 8.78%	499,180 $40.2 Million
Q3 2022 Nov 14, 2022	BUY	$76.35 - $94.18 $3.08 Million - $3.79 Million	40,280 Added 8.78%	499,180 $40.2 Million
Q2 2022 Feb 13, 2024	BUY	$67.99 - $132.89 $24.4 Million - $47.7 Million	358,595 Added 357.5%	458,900 $34.2 Million
Q2 2022 Jul 26, 2022	BUY	$67.99 - $132.89 $24.4 Million - $47.7 Million	358,595 Added 357.5%	458,900 $34.2 Million
Q1 2022 Feb 13, 2024	SELL	$94.08 - $130.2 $63.4 Million - $87.8 Million	-674,255 Reduced 87.05%	100,305 $12.8 Million
Q1 2022 May 11, 2022	SELL	$94.08 - $130.2 $1,881 - $2,604	-20 Reduced 0.02%	100,305 $51.3 Million
Q4 2021 Feb 11, 2022	SELL	$129.87 - $162.82 $12,987 - $16,282	-100 Reduced 0.1%	100,325 $53.9 Million
Q3 2021 Nov 15, 2021	SELL	$106.71 - $143.18 $1,067 - $1,431	-10 Reduced 0.01%	100,425 $54.9 Million
Q2 2021 Aug 12, 2021	BUY	$80.99 - $107.93 $1.22 Million - $1.62 Million	15,055 Added 17.63%	100,435 $42.9 Million
Q1 2021 May 14, 2021	SELL	$84.79 - $104.74 $33,916 - $41,896	-400 Reduced 0.47%	85,380 $30.7 Million
Q4 2020 Feb 10, 2021	BUY	$78.0 - $104.5 $6.69 Million - $8.96 Million	85,780 New	85,780 $31.7 Million

Others Institutions Holding DXCM

# of Institutions

1,014

Shares Held

351M

Call Options Held

5.51M

Put Options Held

5.6M

View Full List

About DEXCOM INC

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $30.9B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

More about DXCM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nicholas Company, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Nicholas Company, Inc. with notifications on news.

Account

Nicholas Company, Inc. Dexcom Inc Transaction History